TWSTTwist Bioscience Corporation

$139.84+355% 1Y

Is the price fair?

What TWST's price assumes

Twist Bioscience Corporation did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 20.3× revenue.

20.3

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
19.7

Price / book · today's price, trailing year to Jun 30, 2026

EV / sales
19.8

EV / sales

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
19.7
EV / EBIToperating margin −34%: the multiple describes the denominator
not meaningful
EV / salestoday's price, trailing year to Jun 30, 2026
19.8
Market capitalisation62.7 million shares, counted Jul 29, 2026
$8.77B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks